Detection of Helicobacter in Shelter dogs / Gökalp et al. ____________________________________________________________________________
2 of 7
INTRODUCTION
Helicobacter is a genus of gram–negative, microaerophilic, spiral
bacteria containing more than 40 species. Non–Helicobacter pylori
helicobacteria (NHPHs) such as Helicobacter heilmannii sensu stricto
(s.s.), Helicobacter bizzozeronii and Helicobacter felis have been
frequently detected in the stomach of dogs (Canis lupus familiaris)
and cats (Felis catus) [1]. The main types of NHPH found in dogs are H.
heilmannii s.s., H. bizzozeronii, H. salomonis, H. felis and H. canis [2].
Most of the NHPHS may also cause illness in humans. Attention should
be paid to the zoonotic importance of NHPHS due to the increased
risk of occurrence in people who are in close and intense contact with
animals [3]. Since Helicobacter pathogens can be excreted through
defecation, expectorating, and vomiting, they present faecal–oral,
oral–oral and gastro–oral transmission routes [4]. Dogs are the natural
hosts of NHPH and harbour these bacteria in their gastric mucosa,
are possible sources of transmission of these bacteria to humans [2].
Invasive and non–invasive methods are used in the diagnosis of
Helicobacter infection. Among invasive methods with endoscopic
biopsy, histological examination, culture, rapid urease test (RUT),
and polymerase chain reaction (PCR) are shown; while among non–
invasive methods, faecal antigen test, urea breath test (UBT), and
serological tests are named [5]. Although gastroscopy, which is within
than other methods, it should be noted that many veterinarians do not
have the opportunity and ability to perform gastroscopy, in addition to
the risks of gastroscopy and associated anaesthesia. For this reason,
non–invasive methods such as serology, culture or PCR, which can
be made from blood, saliva and faecal samples, are preferred [6]. In
addition, it was reported in a study that PCR analyses alone would not
state in the diagnosis of Helicobacter, and this should be supported
by histopathological analyses [7].
The faecal antigen test is highly accurate and a rapid test that
and after treatment. The simplicity of the present method does not
require prior preparation of the patient, but it is recommended not
to apply a proton pump inhibitor (PPI), a 4–week antibiotic treatment,
and bismuth compounds two weeks before the test is performed [8].
Erythrocyte synthesis is regulated by many factors such as
erythropoietin, B
12
, folic acid, and vitamin C. Helicobacter infections
have been associated with vitamin B
12
causing the persistence of vitamin B
12
9]. In addition, it is
known that high levels of TNF–alpha and interleukin levels are present
in Helicobacter
cause structural changes in the gastric epithelial cells [10].
It has been reported that all Helicobacter species are highly sensitive to
and neomycin, and over 90% of dogs with Helicobacter–induced gastritis
are relieved by using a combination of metronidazole, amoxicillin and
famotidine. This treatment procedure, known as triple therapy, lasts at least
21 days, increasing the chance of eradication [11]. The aim of the study was
to determine the presence of Helicobacter in dogs by fecal antigen test and
ELISA methods and to provide early treatment, to have information about
α, IL–1β and C–reactive
protein concentrations and to measure the effects of the presence of the
agent on folic acid (FA) and cobalamin (COB) concentrations.
MATERIALS AND METHODS
Study population and experimental design
The population consisted of 82 dogs in the Temporary Animal
Shelter of the Municipality of Sorgun. Priority was given to those
sampled dogs which showed signs of vomiting and gastritis. Sampling
was done from 82 dogs in the form of scanning. The samples were
collected from different groups of breed, gender and age. Sampling
was done by screening from 82 dogs. Samples were collected from
different breeds, sex and age groups. Samples were composed of 47
dogs from the 0 > 2 age group, 35 dogs from the 2 > 4 age group, 45
dogs from the female animal group and 37 dogs from the male animal
group. According to faecal antigen test results, 2 (4,25%) dogs from
0 > 2 age group and 4 (11,4%) dogs from 2 > 4 age group were positive
for Helicobacter antigen. These dogs were formed the infected group
(n=6) and the antigen negative dogs (n=6) were formed the control
group. The study counted with the approval of the Erciyes University
Animal Experiments Local Ethics Committee (10.09.2020, 20/128).
Clinical examination
The clinical examination of the 82 dogs was performed. The animals
were examined for signs such as loss of appetite, vomiting, abdominal
pain, and increased urge to drink water with dehydration.
Blood and faecal collection
Clinical symptoms frequently encountered in infections originating
from Helicobacter were considered while sampling. 82 dogs with
of sampling were included in the study. For faecal antigen testing, faecal
samples were collected from the rectal region. Blood samples were
taken via vena jugularis into EDTA tubes (Vacusel, Konya, Türkiye) for
haematological analysis; into vacuum tubes (BD Vacutainer, Plymouth,
United Kingdom) for biochemical and serological analysis. The blood
samples obtained were centrifuged in a cooled centrifuge (Hettich
Universal 320R, Germany) at 4.000 g·5 min
-1
. After centrifugation, the
serum was stored at -80°C (ESCO, ESC–UUS–480A, Singapore) until
biochemical and serological analysis.
Treatment protocol
It was paid attention that no antimicrobial treatment was
administered to the dogs for the previous week and that the dogs
sampled were at least one year old. In the dogs to be sampled, those
showing symptoms of vomiting and gastritis were prioritized, and
scanning was performed on 82 dogs that formed the material of the
study. Faecal antigen tests were performed on the faecal samples.
According to the results of faecal antigen tests, positivity (n=6) and
negativity (n=6) were determined. Those found positive were accepted
as infected group and treatment was applied. The infected group
was treated according to the protocol known as triple therapy used
in Helicobacter infections. Amoxicillin–Clavulanate (Croxilex–BID 625
mg tablet, Turkey) 20 mg·kg
-1
PO once a day, Metronidazole (Flagyl
500 mg tablet, France) 15 mg·kg
-1
PO once a day, Ranitidine (Ranitab
150 mg tablet, Turkey) 4 mg·kg
-1
PO once a day. After treatment, stool
samples were collected with sterile test apparatus for 3 weeks and
stool antigen test was repeated.